Literature DB >> 27158925

Decellularized spleen matrix for reengineering functional hepatic-like tissue based on bone marrow mesenchymal stem cells.

Junxi Xiang1,2, Xinglong Zheng1,2, Peng Liu1,2, Lifei Yang2, Dinghui Dong1,2, Wanquan Wu1,2, Xuemin Liu1,2, Jianhui Li2,3, Yi Lv1,2.   

Abstract

BACKGROUND AND AIMS: Decellularized liver matrix (DLM) hold great potential for reconstructing functional hepatic-like tissue (HLT) based on reseeding of hepatocytes or stem cells, but the shortage of liver donors is still an obstacle for potential application. Therefore, an appropriate alternative scaffold is needed to expand the donor pool. In this study, we explored the effectiveness of decellularized spleen matrix (DSM) for culturing of bone marrow mesenchymal stem cells (BMSCs), and promoting differentiation into hepatic-like cells.
METHODS: Rats' spleen were harvested for DSM preparation by freezing/thawing and perfusion procedure. Then the mesenchymal stem cells derived from rat bone marrow were reseeded into DSM for dynamic culture and hepatic differentiation by a defined induction protocol.
RESULTS: The research found that DSM preserved a 3-dimensional porous architecture, with native extracellular matrix and vascular network which was similar to DLM. The reseeded BMSCs in DSM differentiated into functional hepatocyte-like cells, evidenced by cytomorphology change, expression of hepatic-associated genes and protein markers, glycogen storage, and indocyanine green uptake. The albumin production (2.74±0.42 vs. 2.07±0.28 pg/cell/day) and urea concentration (75.92±15.64 vs. 52.07±11.46 pg/cell/day) in DSM group were remarkably higher than tissue culture flasks (TCF) group over the same differentiation period, P< 0.05.
CONCLUSION: This present study demonstrated that DSM might have considerable potential in fabricating hepatic-like tissue, particularly because it can facilitate hepatic differentiation of BMSCs which exhibited higher level and more stable functions.

Entities:  

Keywords:  bone marrow mesenchymal stem cells; decellularized scaffold; differentiation; liver tissue engineering; spleen

Mesh:

Substances:

Year:  2016        PMID: 27158925      PMCID: PMC4993304          DOI: 10.1080/15476278.2016.1185584

Source DB:  PubMed          Journal:  Organogenesis        ISSN: 1547-6278            Impact factor:   2.500


  38 in total

1.  Regeneration: letting the scaffold do the work.

Authors:  Aaron M Rosado; Luke Packard Brewster
Journal:  J Surg Res       Date:  2011-12-13       Impact factor: 2.192

2.  Using a decellularized splenic matrix as a 3D scaffold for hepatocyte cultivation in vitro: a preliminary trial.

Authors:  Xing-Long Zheng; Jun-Xi Xiang; Wan-Quan Wu; Bo Wang; Wen-Yan Liu; Rui Gao; Ding-Hui Dong; Yi Lv
Journal:  Biomed Mater       Date:  2015-08-18       Impact factor: 3.715

3.  Spheroid-based three-dimensional liver-on-a-chip to investigate hepatocyte-hepatic stellate cell interactions and flow effects.

Authors:  Seung-A Lee; Da Yoon No; Edward Kang; Jongil Ju; Dong-Sik Kim; Sang-Hoon Lee
Journal:  Lab Chip       Date:  2013-09-21       Impact factor: 6.799

4.  Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes.

Authors:  Liang Peng; Dong-ying Xie; Bing-Liang Lin; Jing Liu; Hai-peng Zhu; Chan Xie; Yu-bao Zheng; Zhi-liang Gao
Journal:  Hepatology       Date:  2011-07-14       Impact factor: 17.425

Review 5.  An overview of tissue and whole organ decellularization processes.

Authors:  Peter M Crapo; Thomas W Gilbert; Stephen F Badylak
Journal:  Biomaterials       Date:  2011-02-05       Impact factor: 12.479

6.  Cryo-chemical decellularization of the whole liver for mesenchymal stem cells-based functional hepatic tissue engineering.

Authors:  Wei-Cheng Jiang; Yu-Hao Cheng; Meng-Hua Yen; Yin Chang; Vincent W Yang; Oscar K Lee
Journal:  Biomaterials       Date:  2014-01-24       Impact factor: 12.479

7.  In vivo characterization of a decellularized dermis-polymer complex for use in percutaneous devices.

Authors:  Kwangwoo Nam; Rie Matsushima; Tsuyoshi Kimura; Toshiya Fujisato; Akio Kishida
Journal:  Artif Organs       Date:  2014-06-25       Impact factor: 3.094

8.  Decellularization of human and porcine lung tissues for pulmonary tissue engineering.

Authors:  John D O'Neill; Rachel Anfang; Annabelle Anandappa; Joseph Costa; Jeffrey Javidfar; Holly M Wobma; Gopal Singh; Donald O Freytes; Matthew D Bacchetta; Joshua R Sonett; Gordana Vunjak-Novakovic
Journal:  Ann Thorac Surg       Date:  2013-07-18       Impact factor: 4.330

9.  Human-scale whole-organ bioengineering for liver transplantation: a regenerative medicine approach.

Authors:  Hiroshi Yagi; Ken Fukumitsu; Kazumasa Fukuda; Minoru Kitago; Masahiro Shinoda; Hideaki Obara; Osamu Itano; Shigeyuki Kawachi; Minoru Tanabe; Gina M Coudriet; Jon D Piganelli; Thomas W Gilbert; Alejandro Soto-Gutierrez; Yuko Kitagawa
Journal:  Cell Transplant       Date:  2012-08-27       Impact factor: 4.064

10.  Regeneration and experimental orthotopic transplantation of a bioengineered kidney.

Authors:  Jeremy J Song; Jacques P Guyette; Sarah E Gilpin; Gabriel Gonzalez; Joseph P Vacanti; Harald C Ott
Journal:  Nat Med       Date:  2013-04-14       Impact factor: 53.440

View more
  4 in total

1.  Existence of Neural Stem Cells in Mouse Spleen.

Authors:  Koichi Tomita; Hiroshi Ishikawa
Journal:  ScientificWorldJournal       Date:  2019-01-09

Review 2.  Sterilization and disinfection methods for decellularized matrix materials: Review, consideration and proposal.

Authors:  Meihan Tao; Tianrang Ao; Xiaoyan Mao; Xinzhu Yan; Rabia Javed; Weijian Hou; Yang Wang; Cong Sun; Shuang Lin; Tianhao Yu; Qiang Ao
Journal:  Bioact Mater       Date:  2021-02-27

Review 3.  Recent Advances in Liver Engineering With Decellularized Scaffold.

Authors:  Qingqing Dai; Wei Jiang; Fan Huang; Fei Song; Jiqian Zhang; Hongchuan Zhao
Journal:  Front Bioeng Biotechnol       Date:  2022-02-10

4.  Spleen extracellular matrix provides a supportive microenvironment for β-cell function.

Authors:  Layasadat Khorsandi; Mahmoud Orazizadeh; Darioush Bijan Nejad; Abbas Heidari Moghadam; Fereshteh Nejaddehbashi; Yousef Asadi Fard
Journal:  Iran J Basic Med Sci       Date:  2022-09       Impact factor: 2.532

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.